Revolution Medicines RVMD
NASDAQ RVMD
$210.96 +1.73 (+0.83%)
As of: Sep 3, 2026 · 3:55 PM EDT

Revolution Medicines (RVMD) Sales of Property, Plant and Equipment (2019)

Analysis

Revolution Medicines (RVMD) Sales of Property, Plant and Equipment (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 141.44 Bn 133.59 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.58 Bn 78.58 Bn 3.93 Bn -
3 Argenx Se 64.69 Bn 59.51 Bn 1.37 Bn -
4 Moderna 58.79 Bn 53.65 Bn 52.00 Mn -
5 Revolution Medicines 44.35 Bn 44.35 Bn - -
6 BeOne Medicines 40.38 Bn 35.28 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.30 Bn 31.99 Bn 992.69 Mn -
8 Royalty Pharma 28.41 Bn 27.57 Bn - -
9 Insmed 27.45 Bn 26.29 Bn 358.27 Mn -
10 Incyte 25.64 Bn 21.10 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4,000.00
Sep 30, 2019 5,000.00
Jun 30, 2019 85,000.00
Mar 31, 2019 102,000.00